riluzole has been researched along with Androgen-Independent Prostatic Cancer in 1 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wadosky, KM | 1 |
Shourideh, M | 1 |
Goodrich, DW | 1 |
Koochekpour, S | 1 |
1 other study available for riluzole and Androgen-Independent Prostatic Cancer
Article | Year |
---|---|
Riluzole induces AR degradation via endoplasmic reticulum stress pathway in androgen-dependent and castration-resistant prostate cancer cells.
Topics: Activating Transcription Factor 6; Androgens; Autophagy; Cell Line, Tumor; Drug Interactions; Endopl | 2019 |